Phathom Pharmaceuticals target price cut to $7.50 from $10 by Leerink Partners
PHAT•Leerink Partners cut its target price for Phathom Pharmaceuticals to $7.50 from $10.
Related News
Chardan Capital Markets cuts Alnylam Pharmaceuticals price target to $375 from $425
ALNY•
J.P. Morgan Securities raises Nearthlab stake to 5.06%
JPM•
Stocks slump, bonds leap as AI giants' spending spooks investors
SPY•
Reddit: B. Riley cuts target price to $190 from $270
RDDT•
Allegro Microsystems target price cut to $50 from $57 by Needham
ALGM•